Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on Advanced Liver Cancer: Evaluating Livmoniplimab and Budigalimab in Patients Without Prior Systemic Treatment
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Atezolizumab and Bevacizumab for Patients with High-Risk Hepatocellular Carcinoma After Surgery or Ablation
Not recruiting
Investigated Drugs:
+3
Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy
Not recruiting
Investigated Drugs:
Study of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer
Not recruiting
Investigated Drugs:
Study on Hepatocellular Carcinoma: Evaluating Livmoniplimab and Budigalimab for Patients with Advanced or Metastatic Cancer After First-Line Treatment
Not recruiting
Investigated Diseases:Investigated Drugs:
